Molecular Diagnostics
Highly Sensitive Liquid Biopsy Technique Brings Personalized Cancer Monitoring a Step Closer
A modified liquid biopsy method enables detection of circulating tumor DNA (ctDNA) with much greater sensitivity than previously used techniques and demonstrates the potential to revolutionize all aspects of cancer care, from early detection to personalized treatment and monitoring. More...29 Jun 2020
Gut Microbiome Dysbiosis Characterized in Parkinson’s Disease
Parkinson’s disease (PD) is a common, progressive, and debilitating disease, which currently cannot be prevented or cured. With the exception of rare genetic forms, the cause of PD is unknown. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement. More...29 Jun 2020
Serum Mir‐22 Prognostic Marker Explored for Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive hematopoietic stem cell malignancy that is characterized by the clonal proliferation of myeloid precursors. Abnormal accumulation of leukemic blasts in the bone marrow, blood, and other tissues results in significant reductions of normal blood cells. More...25 Jun 2020
Isothermal Amplification Method Used to Detect Salmonella Subtypes
Salmonella is a common cause of foodborne disease worldwide, including Australia. More than 85% of outbreaks of human salmonellosis in Australia were caused by five Salmonella serovars. Rapid, accurate, and sensitive identification of Salmonella serovars is vital for diagnosis and public health surveillance. More...25 Jun 2020
Serum Neurofilament Light Chain Is a Potential Prognostic Biomarker for Frontotemporal Lobar Degeneration
A recent study has confirmed previous results showing that the protein serum neurofilament light chain is a potential prognostic biomarker for frontotemporal lobar degeneration. More...24 Jun 2020
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Laboratory Software
ArtelWare
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
In Other News
Blood Test Predicts Prostate Cancer Treatment Response
A Simple Paper-Based, Wearable Device for Long Term Sweat Analysis
Sensitive Separation Device Enables Diagnostic Analysis of Cancer Exosomes
Tumor Mutation and Immune Microenvironment Revealed in Colorectal Cancer
Polygenic Risk Scores Highlight Potential for Developing Coronary Artery Disease
Streamlined Assay Improves Prenatal Detection of Alpha-Thalassemia
Precision Oncology Confers Clinical Benefit in Relapsed Pediatric Cancer
Blood Protein Biomarkers Predict Outcome of a Patient’s COVID-19 Infection
Study Evaluates Molecular Diagnostics Tests for SARS-CoV-2
Saliva-Based Assay Developed for HPV-Driven Oropharyngeal Cancer
Changes in Bacterial Load and Serum Cytokine Levels Predict Likelihood of Dying from Sepsis
Serum MicroRNAs Predict Likelihood of Pregnant Women Developing Pre-Eclampsia
Elevated Plasma Neurofilament Light Chain Predicts Worsening of Muscular Sclerosis Symptoms
MicroRNA Biomarker Panel Identifies Patients at Risk for Pancreatic Cancer Metastasis to the Lymph Nodes
Representative Tumor Sampling Method Lessens Molecular Analyses Bias
An Analytical Method to Monitor Dietary Fat Intake
Germline Risk Variants Found in Prostate Cancer Patients
Non-Invasive Blood Assay Can Detect Early Colorectal Cancer
New Blood Test Can Determine When an Individual Was Exposed to a Pathogenic Microorganism
Rare Kidney Cancer Marked by Molecular Features
Higher Concentrations of COVID-19 Receptor Protein Found in Men’s Plasma
Blood Test Shows Promise for Predicting Cancer
Knowing the Ethnic Specificity of Urinary Biomarker Proteins Could Refine Diagnosis of Lupus Nephritis
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.